• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . COVID-19 hospitalizations in five California hospitals: a retrospective cohort study

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2021 Sep 10;21(1):938.
doi: 10.1186/s12879-021-06640-4.
COVID-19 hospitalizations in five California hospitals: a retrospective cohort study


Miriam Nuño[SUP] 1 2 [/SUP], Yury García[SUP] 3 4 [/SUP], Ganesh Rajasekar[SUP] 5 [/SUP], Diego Pinheiro[SUP] 6 [/SUP], Alec J Schmidt[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Background: The novel coronavirus pandemic has had a differential impact on communities of color across the US. The University of California hospital system serves a large population of people who are often underrepresented elsewhere. Data from hospital stays can provide much-needed localized information on risk factors for severe cases and/or death.
Methods: Patient-level retrospective case series of laboratory-confirmed COVID-19 hospital admissions at five UC hospitals (N = 4730). Odds ratios of ICU admission, death, and a composite of both outcomes were calculated with univariate and multivariate logistic regression based on patient characteristics, including sex, race/ethnicity, and select comorbidities. Associations between comorbidities were quantified and visualized with a correlation network.
Results: Overall mortality rate was 7.0% (329/4,730). ICU mortality rate was 18.8% (225/1,194). The rate of the composite outcome (ICU admission and/or death) was 27.4% (1298/4730). Comorbidity-controlled odds of a composite outcome were increased for age 75-84 (OR 1.47, 95% CI 1.11-1.93) and 85-59 (OR 1.39, 95% CI 1.04-1.87) compared to 18-34 year-olds, males (OR 1.39, 95% CI 1.21-1.59) vs. females, and patients identifying as Hispanic/Latino (OR 1.35, 95% CI 1.14-1.61) or Asian (OR 1.43, 95% CI 1.23-1.82) compared to White. Patients with 5 or more comorbidities were exceedingly likely to experience a composite outcome (OR 2.74, 95% CI 2.32-3.25).
Conclusions: Males, older patients, those with multiple pre-existing comorbidities, and those identifying as Hispanic/Latino or Asian experienced an increased risk of ICU admission and/or death. These results are consistent with reported risks among the Hispanic/Latino population elsewhere in the United States, and confirm multiple concerns about heightened risk among the Asian population in California.

Keywords: Comorbidities; Composite outcome; Coronavirus disease 2019; Hospitalization; In-hospital mortality; Intensive care unit; Severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom